Management of acute and delayed chemotherapy-induced nausea and vomiting: role of netupitant–palonosetron combination

Management of acute and delayed chemotherapy-induced nausea and vomiting: role of netupitant–palonosetron combination

Piotr K JanickiDepartment of Anesthesiology and Perioperative Medicine, Milton S Hershey Medical Center, Pennsylvania State University College of Medicine, Hershey, PA, USAPurpose: The purpose of this review is to summarize and discuss the recently published data (both original studies and reviews)...

Full description

Bibliographic Details
Main Author:	Janicki PK
Format:	Article
Language:	English
Published:	Dove Medical Press 2016-05-01
Series:	Therapeutics and Clinical Risk Management
Subjects:	Keywords: chemotherapy-induced nausea nad vomiting palonosetron netupitant NEPA safety pharmacology outcomes
Online Access:	https://www.dovepress.com/management-of-acute-and-delayed-chemotherapy-induced-nausea-and-vomiti-peer-reviewed-article-TCRM

Similar Items

Management of chemotherapy-induced nausea and vomiting by risk profile: role of netupitant/palonosetron
by: Lorusso V
Published: (2016-06-01)

NEPA, a new fixed combination of netupitant and palonosetron, is a cost-effective intervention for the prevention of chemotherapy-induced nausea and vomiting in the UK
by: Helene Cawston, et al.
Published: (2017-03-01)

Palonosetron in the prevention of chemotherapy-induced nausea and vomiting in Italy: pharmacoeconomic and clinical aspects
by: Lorenzo Pradelli, et al.
Published: (2007-06-01)

Identification of optimal contemporary antiemetic prophylaxis for doxorubicin-cyclophosphamide chemotherapy in Chinese cancer patients: post-hoc analysis of 3 prospective studies
by: Winnie Yeo, et al.
Published: (2021-08-01)

Fixed combination of oral NEPA (netupitant‐palonosetron) for the prevention of acute and delayed chemotherapy‐induced nausea and vomiting in patients receiving multiple cycles of chemotherapy: Efficacy data from 2 randomized, double‐blind phase III studies
by: Lee Schwartzberg, et al.
Published: (2019-05-01)

Efficacy of NEPA, a fixed antiemetic combination of netupitant and palonosetron, vs a 3‐day aprepitant regimen for prevention of chemotherapy‐induced nausea and vomiting (CINV) in Chinese patients receiving highly emetogenic chemotherapy (HEC) in a randomized Phase 3 study
by: Jianhua Chang, et al.
Published: (2020-07-01)

Aprepitant in combination with palonosetron for the prevention of postoperative nausea and vomiting in female patients using intravenous patient-controlled analgesia
by: Jae Hwa Yoo, et al.
Published: (2018-12-01)

Prospective randomized trial with Palonosetron verses ondensetron for postoperative nausea and vomitting in general surgical population
by: Meenal Agarwal, et al.
Published: (2016-10-01)

The effect of combination treatment using palonosetron and dexamethasone for the prevention of postoperative nausea and vomiting versus dexamethasone alone in women receiving intravenous patient-controlled analgesia
by: Seung-hwa Ryoo, et al.
Published: (2015-06-01)

Comparison of efficacy of palonosetron-dexamethasone combination with palonosetron or dexamethasone alone for prophylaxis against post-operative nausea and vomiting in patients undergoing laparoscopic cholecystectomy
by: Arindam Chatterjee, et al.
Published: (2017-01-01)

Evaluation of the ability of continuous palonosetron infusion, using a patient-controlled analgesia device, to reduce postoperative nausea and vomiting
by: Ji Won Kang, et al.
Published: (2014-08-01)

Antiemetic efficacy and safety of granisetron or palonosetron alone and in combination with a corticosteroid for ABVD therapy-induced nausea and vomiting
by: Mayako Uchida, et al.
Published: (2018-01-01)

A comparative study between palonosetron and granisetron to prevent postoperative nausea and vomiting after laparoscopic cholecystectomy
by: Dhurjoti Prosad Bhattacharjee, et al.
Published: (2010-01-01)

Evolving role of neurokinin 1-receptor antagonists for chemotherapy-induced nausea and vomiting
by: Navari RM, et al.
Published: (2018-10-01)

Netupitant/palonosetron (NEPA) and dexamethasone for prevention of emesis in breast cancer patients receiving adjuvant anthracycline plus cyclophosphamide: a multi-cycle, phase II study
by: Roberta Caputo, et al.
Published: (2020-03-01)

The effectiveness of NEPA in the prevention of chemotherapy-induced nausea vomiting among chemo naive patients in an Indian setting
by: Bharat Vaswani, et al.
Published: (2021-05-01)

A randomized study to compare palonosetron with ondansetron for prevention of postoperative nausea and vomiting following middle ear surgeries
by: Shubhangi Sharma, et al.
Published: (2019-01-01)

Efficacy of the combination use of aprepitant and palonosetron for improving nausea in various moderately emetogenic chemotherapy regimens
by: Naohisa Yoshida, et al.
Published: (2019-01-01)

Intravenous palonosetron compared with a combination of ramosetron and dexamethasone in preventing post operative nausea and vomiting in patients undergoing gynaecological surgeries under spinal anaesthesia, a randomised study
by: Archana B Narayanappa, et al.
Published: (2017-01-01)

A comparison of palonosetron and dexamethasone for postoperative nausea and vomiting in orthopedic patients receiving patient-controlled epidural analgesia
by: Byung-Gun Kim, et al.
Published: (2017-10-01)

Comparison of palonosetron with ondansetron in prevention of postoperative nausea and vomiting in patients receiving intravenous patient-controlled analgesia after gynecological laparoscopic surgery
by: Yu Yil Kim, et al.
Published: (2013-02-01)

Comparison of palonosetron and dexamethasone with ondansetron and dexamethasone for postoperative nausea and vomiting in postchemotherapy ovarian cancer surgeries requiring opioid-based patient-controlled analgesia: A randomised, double-blind, active controlled study
by: Amit Kumar, et al.
Published: (2018-01-01)

Economic analysis of palonosetron versus granisetron in the standard triplet regimen for preventing chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy in Japan (TRIPLE phase III trial)
by: Hisanori Shimizu, et al.
Published: (2018-12-01)

Open-label observational study to assess the efficacy and safety of aprepitant for chemotherapy-induced nausea and vomiting prophylaxis in Indian patients receiving chemotherapy with highly emetogenic chemotherapy/moderately emetogenic chemotherapy regimens
by: Hingmire Sachin, et al.
Published: (2015-01-01)

Investigation of nausea and vomiting in cancer patients undergoing chemotherapy
by: Maria Lavdaniti, et al.
Published: (2014-10-01)

Effects of pretreatment with intravenous palonosetron for propofol-remifentanil-based anesthesia in breast and thyroid cancer surgery: a double-blind, randomized, controlled study
by: Kye Hyeok Lee, et al.
Published: (2014-07-01)

Differential clinical pharmacology of rolapitant in delayed chemotherapy-induced nausea and vomiting (CINV)
by: Rashad N, et al.
Published: (2017-03-01)

Ice massage on chemotherapy induced nausea and vomiting
by: Mehdi Sadeghi Shermeh, et al.
Published: (2012-05-01)

Recent advances in pharmacotherapy of chemotherapy-induced nausea and vomiting
by: Prasan R Bhandari
Published: (2012-01-01)

Laparoskopik kolesistektomi sonrası postoperatif bulantı ve kusmanın önlenmesinde tropisetron ve palonosetron’un karşılaştırılması: Randomize, çift-kör çalışma
by: Recep Aksu, et al.
Published: (2016-09-01)

A Phase II single-arm trial of palonosetron for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in malignant glioma patients receiving multidose irinotecan in combination with bevacizumab
by: Affronti ML, et al.
Published: (2016-12-01)

Effects of Matricaria Chamomilla on the Severity of Nausea and Vomiting Due to Chemotherapy
by: fatemeh borhan, et al.
Published: (2017-11-01)

Palonosetron has superior prophylactic antiemetic efficacy compared with ondansetron or ramosetron in high-risk patients undergoing laparoscopic surgery: a prospective, randomized, double-blinded study
by: Sung-Hoon Kim, et al.
Published: (2013-06-01)

Impact of Olanzapine on Refractory Chemotherapy-Induced Nausea and Vomiting: a Retrospective Study
by: Seibert, Laurel, et al.
Published: (2013)

Effect of Music Therapy on Chemotherapy Nausea and Vomiting in Children with Malignancy
by: * AS (MSc.). Sadat Hoseini
Published: (2009-11-01)

Effect of Music Therapy on Chemotherapy Nausea and Vomiting in Children with Malignancy
by: AS Sadat Hoseini
Published: (2009-10-01)

The Effect of Transdermal Scopolamine for the Prevention of Postoperative Nausea and Vomiting
by: Maria A. Antor, et al.
Published: (2014-04-01)

Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics
by: May MB, et al.
Published: (2016-05-01)

Evaluating the antiemetic administration consistency to prevent chemotherapy-induced nausea and vomiting with the standard guidelines: a prospective observational study
by: Vazin A, et al.
Published: (2017-09-01)

The effect of hearing Quran verses on reducing chemotherapy-induced nausea and vomiting in cancer patients referring to Imam Hossein Hospital
by: Shaghayegh Kamian, et al.
Published: (2019-10-01)